Announcement on Convening the 2025 Annual Performance Briefing
Filed with SSE · · 2 pages · Chinese
Shanghai Rightongene Biotechnology Co. Ltd. on 6ix
Earlier from Shanghai Rightongene Biotechnology
- Announcement on Reply to Inquiry Letter for Information Disclosure Supervision of 2025 Annual Report
- Report for Q1 2026
- Notice on Convening the 2025 Annual General Meeting
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Obtaining Government Subsidies
Later from Shanghai Rightongene Biotechnology
- Notice on Convening the 1st Extraordinary General Meeting in 2026
- Announcement on Shareholding Reduction Plan for Shareholders
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Indicative Announcement on Change in Equity of a Shareholder Holding More Than 5% of the Shares Reaching an Integral Multiple of 5%
Follow Shanghai Rightongene Biotechnology into a list and get an email when it puts out news.
Follow Shanghai Rightongene Biotechnology